NCT03429192View on ClinicalTrials.gov

A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

2,653

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

March 30, 2018

Study Completion Date

March 30, 2018

Conditions
Non-small Cell Lung Cancer
Interventions
PROCEDURE

Surgery

Surgeries plus dissection of lymph nodes

Trial Locations (9)

100029

China-Japan Friendship Hospital, Beijing

100853

China People's Liberation Army Hospital, Beijing

200030

Shanghai Chest Hospital, Shanghai

210009

Jiangsu Cancer Hospital, Nanjing

310003

First Hospital Affiliated to Zhejiang University, Hangzhou

430030

Tongji Hospital Affiliated to Huaxi Technology University, Wuhan

450008

Henan Cancer Hospital, Zhengzhou

610041

Huaxi Hospital Affiliate to Sichuan University, Chengdu

710000

Xi'an Tangdu Hospital, Xi'an

All Listed Sponsors
collaborator

LinkDoc Technology (Beijing) Co. Ltd.

INDUSTRY

lead

Tianjin Chest Hospital

OTHER

NCT03429192 - A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter